Review
Copyright ©2012 Baishideng.
World J Transplant. Feb 24, 2012; 2(1): 9-18
Published online Feb 24, 2012. doi: 10.5500/wjt.v2.i1.9
Table 2 Outcome of living donor renal transplantation performed outside recipient countries
Study (country), periodnGraft survival (%)
Patient survival (%)
TypeComments
1-yr5-yr1-yr5-yr
Tsai et al[6] (United Arab Emirates), 1987-2006215T55.081.5Both LRD and LURDChina; 10-yr survival figures; Higher risk of cancer in T group
321H60.089.3
Kennedy et al[23] (Australia), 1990-20041666.085.0LURDCommercial transplants in India and China. Aspergillosis in one patient
Kwon et al[25] (South Korea), 1999-2005462T96.8 (death censored)96.5LURDAll transplants performed in China. Fifteen patients died; 42.5% complication rate. Results based on returning patients’ accounts
Ivanovski et al[41] (Macedonia), 2006-200736T60.078.0Transplants in India and Pakistan; 16/36 wound infections; active HCV+ in 9; seven died; 3 MI; TN in 3; 56% developed complication in early post op period. Acute rejection in 9/36. Poor communication
H100.0100.0
Krishnan et al[42] (UK), 1996-200636T87.083.0CommercialIndonesians in the UK. Poor clinical outcome in tourists - 42% had major infections
40H97.597.5Living donor in UK
Rizvi et al[43] (Pakistan), 1997-200718094.080.0LRDMortality 16 (6%) for LRD and 34 (27%) for LURD
12686.045.0LURD
Sever et al[44] (Turkey), 1992-199911566.080.0Commercial transplants in India, Iran, Iraq. Significant medical complications
Ackoundou-N’Guessan et al[45] (Ivory Coast), 1995-200916T93.080.093.053.0BothPatients from Ivory Coast; two losses from AR; 5/16 died during period; death-censored graft survival
Gill et al[46] (US), 1995-20073389.0Transplants in China, Iran, Philippines, etc.; three graft losses; 17/33 (52%) had infections; one death; AR 30% vs 12% in home transplants; survival figures inferior to cohort of 66 matched local patients
UCLA98.0UCLA - University of California Los Angeles
Geddes et al[47] (Scotland), 2000-200718Travel from Scotland to Pakistan for transplants. No deaths; Malaria in one; acute rejection rate 11.1%; eGFR at 1 yr 51.8 mL/min every BSA1.73 m2
Majid et al[48] (United Arab Emirates), 1993-200945100.0100.0100.0LRD (10)Paediatric; DBD 2; three death within 4 mo of transplantation; 10-yr survival
87.843.491.2LURD (33)
Ghods[49] (Iran), 1986-2006199590.574.493.987.1496 LRD; 1499 LURDKaplan-Meier estimates; rates for LURD. 10-yr graft and patient survival rates were 49% and 72% respectively. Paid and regulated system in Iran
Rizvi et al[50] (Pakistan), 1990-2002100090.075.095.085.0Private-public partnership model
Salahudeen et al[51] (United Arab Emirates/Oman), 1984-198813181.5Transplants performed in India. 25 deaths in first year; HIV = 5; HBV = 3; Septicaemia in 4. Insufficient information to patients
Morad et al[52] (Malaysia), 1990-199628990.093.0IndiaComparable results to local transplants
12690.092.0China
25891.096.0Local (Malaysia)
LURD Transplant Study Group 1997[53], 1978-199354090.072.097.092.0Commercial22 centres in India; Higher infection risk amongst commercial transplants: Hep B infection 8.1 v 1.4 in commercial renal transplantation
7590.083.095.091.0Emotionaly related
UK Transplant[54], 2002-2004100095.090.098.096.0BothFirst transplants only